TP53 and posterior cortical atrophy: In addition, EZH2 inhibition was shown to reverse anti-androgen resistance in murine and human models of PCa that exhibited increased lineage plasticity, metastatic potential, and treatment resistance due to RB-1 and p53 loss [24].